Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
Globe Newswire•28/08/2026•05:45 ET
0
Whiz Insights
ACACIA-HCM is the First Phase 3 Clinical Trial to Successfully Demonstrate Statistically Significant Improvements Across Both Patient-Reported and Physician-Assessed Endpoints in Non-Obstructive HCM
Supplemental New Drug Application to be Submitted to FDA in Fourth Quarter
Get started
Create a free account to read the full story.